Alterations in Serotonergic Functions in Cocaine Addicts - 1
NCT00000312 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
The purpose of this study is to evaluate alterations in the serotonergic system in cocaine addicts and attempt to dissociate changes secondary to cocaine use from those associated with premorbid characteristics.
Conditions
- Cocaine-Related Disorders
Interventions
- DRUG
-
M-CPP
Sponsors & Collaborators
-
US Department of Veterans Affairs
collaborator FED -
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Laure Buydens-Branchey, M.D. · VA Medical Center
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 25 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Serotonin, Impulsivity, and Cocaine Dependence Treatment
NCT00297505 ·Status: COMPLETED ·Phase: PHASE2
-
Selegiline in Outpatient Treatment for Cocaine Dependence - 1
NCT00000336 ·Status: COMPLETED ·Phase: PHASE2
-
New Approaches to Cocaine Abuse Medications (A) - 6
NCT00000271 ·Status: COMPLETED ·Phase: PHASE2
-
Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts
NCT00142779 ·Status: COMPLETED ·Phase: NA
-
The Effect of Glutamatergic Modulation on Cocaine Self-administration
NCT02596022 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence
NCT01984177 ·Status: COMPLETED
-
Citalopram for Cocaine Dependence
NCT01535573 ·Status: COMPLETED ·Phase: PHASE2
-
Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence
NCT00376558 ·Status: COMPLETED ·Phase: NA
-
Brain Changes in Stimulant Dependent Subjects - 8
NCT00000343 ·Status: COMPLETED ·Phase: PHASE4
-
Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders
NCT03344419 ·Status: SUSPENDED ·Phase: PHASE3
-
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
NCT00000276 ·Status: TERMINATED ·Phase: PHASE1
-
Clinical Neurobiology of Serotonin and Addiction
NCT00732901 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1
NCT00000245 ·Status: COMPLETED ·Phase: PHASE2
-
Impulsivity, Neural Deficits and Cocaine Addiction
NCT00744601 ·Status: COMPLETED
-
Rebalancing the Serotonergic System in Cocaine Dependence
NCT03266939 ·Status: WITHDRAWN ·Phase: PHASE1
-
Cocaine Use Disorder and Cortical Dopamine
NCT03349606 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
IV Cocaine Abuse: A Laboratory Model - 1
NCT00000212 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Abuse and ADHD - 10
NCT00000275 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Cocaine Addiction Using mGluR5 PET and fMRI
NCT03471182 ·Status: COMPLETED ·Phase: PHASE1
-
Gender and Neural Substrates of Stress and Craving
NCT00756925 ·Status: COMPLETED
-
Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1
NCT00032916 ·Status: UNKNOWN ·Phase: PHASE1
-
Reserpine for the Treatment of Cocaine Dependence - 1
NCT00033033 ·Status: COMPLETED ·Phase: PHASE2
-
Modafinil for the Treatment of Cocaine Dependence - 1
NCT00100100 ·Status: COMPLETED ·Phase: PHASE2
-
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
NCT00015275 ·Status: COMPLETED ·Phase: PHASE4
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
NCT00040066 ·Status: UNKNOWN ·Phase: PHASE1